The Top Tech of 2016
What’s next in the world of CAR-T? A whole lot:
- Additional cancer and autoimmune disease indications in preclinical development.
- Added safety features.
- More affordable “off the shelf” versions of the technology.
Let’s first welcome 2017 by reviewing how this key therapeutic works; we will continue our discussion by covering the future of CAR-T in our next edition.